Saenger, AK;
Jaffe, AS;
Body, R;
Collinson, PO;
Kavsak, PA;
Lam, CSP;
Lefèvre, G;
Omland, T;
Ordóñez-Llanos, J;
Pulkki, K;
et al.
Saenger, AK; Jaffe, AS; Body, R; Collinson, PO; Kavsak, PA; Lam, CSP; Lefèvre, G; Omland, T; Ordóñez-Llanos, J; Pulkki, K; Apple, FS
(2019)
Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB).
Clin Chem Lab Med, 57 (5).
pp. 633-640.
ISSN 1437-4331
https://doi.org/10.1515/cclm-2018-0905
SGUL Authors: Collinson, Paul
Preview |
|
PDF
Published Version
Available under License ["licenses_description_publisher" not defined].
Download (120kB)
| Preview
|
Abstract
Two interferences recently brought to the forefront as patient safety issues include hemolysis (hemoglobin) and biotin (vitamin B7). The International Federation for Clinical Chemistry Committee on Cardiac Biomarkers (IFCC-CB) obtained input from a majority of cTn and NP assay manufacturers to collate information related to high-sensitivity (hs)-cTnI, hs-cTnT, contemporary, and POC cTn assays, and NP assays interferences due to hemolysis and biotin. The information contained in these tables was designed as educational tools to aid laboratory professionals and clinicians in troubleshooting cardiac biomarker analytical results that are discordant with the clinical situation.
Statistics
Item downloaded times since 29 Jan 2019.
Actions (login required)
|
Edit Item |